At a glance
ClinicalIndex Comparison Record- ✓English-speaking patients
- ✓Ages 18 to 99 years old
- ✓Scheduled to undergo a screening breast MRI study
- ✓Capable and willing to provide signed informed consent
- ✕Claustrophobia
- ✕Metallic implants or foreign bodies (pacemaker, intracranial aneurysm clip, bladder stimulator, cochlear implant, or metal near eyes or pelvis) that would create imaging artifact
- ✕Known hypersensitivity to contrast agent refractory to standard medications
- ✕Impaired kidney function (serum creatinine >1.8 mg/dL or GFR <60) unless anuric on dialysis
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study
In Brief
A clinical study evaluating MR Fingerprinting for Breast Screening. Completed, enrolled 28 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate potential clinical efficacy of a novel magnetic resonance imaging (MRI) approach, MR fingerprinting, capable of providing quantitative measures of important tissue properties, which could provide important insights into normal breast tissue. This new MRI sequence will be added to the screening breast Dynamic Contrast Enhanced (DCE) MRI for high risk normal patients.
Study Details
Timeline
Interventions
The MR fingerprinting technique requires less than 15 minutes total and will be added before and after the standard MRI sequence.